Pipofezine (Azafen or Azaphen) is a tricyclic antidepressant (TCA) approved in Russia for the treatment of depression. It was introduced in the late 1960s and is still used today.

Pipofezine has been shown to act as a potent inhibitor of the reuptake of serotonin. In addition to its antidepressant action, pipofezine has sedative effects as well, indicating antihistamine activity. Other properties such as anticholinergic or antiadrenergic actions are less clear but are likely.





This page contains text from Wikipedia, the Free Encyclopedia - http://en.wikipedia.org/wiki/Pipofezine

This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.